CB1 Blockade Affected Expression of Morphine Sensitization More Than Its Development in Rats

A rat study found that blocking CB1 receptors altered the expression of morphine sensitization more clearly than its induction. Measurements of brain endocannabinoids also changed in different directions across regions and experimental phases.

Timing changed the intervention question

The investigators studied both development of the sensitized response during repeated morphine exposure and its later expression. Administering SR141716A during the expression phase modified signs of sensitization. Giving it alongside morphine during induction only slightly affected behavioral responses. Those are different intervention windows, not conflicting versions of one result.

Anandamide and 2-AG were not uniform markers

The study measured anandamide and 2-arachidonoylglycerol, or 2-AG, in brain regions including the caudate putamen, nucleus accumbens, hippocampus and prefrontal cortex. Changes differed between the two endocannabinoids, sometimes ran in opposite directions and depended on region and phase. These brain-content measurements should not be substituted for blood THC concentrations or a cannabis exposure test.

Sensitization is not a clinical diagnosis

The animal model used behavioral sensitization to investigate drug-related adaptation. It does not establish a person's addiction status, future drug use or response to treatment. The authors framed endocannabinoid changes as a possible neurochemical basis for interactions between opioid and cannabinoid systems.

The practical interpretive point is temporal: a treatment affecting an established response need not prevent that response from developing. Likewise, a change in one brain lipid cannot stand in for the entire endocannabinoid system. Both distinctions matter when evaluating broad claims about cannabis and opioid adaptation.

Related: interpreting cannabis tolerance claims.

Research cited

Viganò D; Valenti M; Cascio MG; Di Marzo V; Parolaro D; Rubino T. Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. The European journal of neuroscience (2004). doi:10.1111/j.1460-9568.2004.03645.x. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

What Skin Tags Along an Abrasion Can Show About Direction

Knight’s Forensic Pathology explains how superficial skin fragments can help interpret a scraping injury.

Spread the love

Read Article: What Skin Tags Along an Abrasion Can Show About Direction

Why Stomach Contents Provide an Uncertain Timeline After Death

Knight’s Forensic Pathology explains how meal composition and stress complicate estimates based on stomach contents.

Spread the love

Read Article: Why Stomach Contents Provide an Uncertain Timeline After Death

What Did the Confirmatory Phase 3 MDMA-Assisted Therapy Trial Add?

The MAPP2 trial replicated symptom and functional improvements in a more ethnoracially diverse PTSD sample. It also left important questions about blinding, long-term outcomes, exclusions, and sponsor involvement.

Spread the love

Read Article: What Did the Confirmatory Phase 3 MDMA-Assisted Therapy Trial Add?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us